Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of dextromethorphan hydrobromide tablets (fasting and postprandial) in healthy Chinese subjects
ChiCTR2300073130Phase 4Not yet recruiting
- Sponsor
- Guangzhou Panyu District Central Hospital
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dextromethorphan in cough (4 arms), sponsored by Guangzhou Panyu District Central Hospital. Primary endpoints: Cmax, AUC0-∞ and 3 more. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
dextromethorphan
03
Conditions
cough
Beyond the preview
Go deeper on ChiCTR2300073130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073130.